logo-loader

Clinigen boss hails launch of breast cancer drug Halaven in important South African market

Last updated: 13:24 01 Mar 2017 GMT, First published: 08:24 01 Mar 2017 GMT

CEO of Clinigen PLC (LON:CLIN) Shaun Chilton talks to Proactive about the UK Pharma group making the breast cancer drug Halaven (eribulin) available in South Africa for the first time for women in an advanced stage of the disease.

Caledonia Mining tackles 2023 challenges with optimism for 2024 as it...

Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) chief executive Mark Learmonth tells Proactive's Stephen Gunnion the company faced a challenging 2023, primarily due to poor production in the first half of the year at its core asset, the Blanket Mine in Zimbabwe, and an underperformance...

35 minutes ago